WHO ICTRP trial
An open-label, multi-center study to document the efficacy, safety and…
EUCTR2004-002032-26-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-002032-26-ES |
|---|---|
| Public title | An open-label, multi-center study to document the efficacy, safety and tolerability of long-term administration of RO0503821 in patients with chronic renal anemia |
| Scientific title | An open-label, multi-center study to document the efficacy, safety and tolerability of long-term administration of RO0503821 in patients with chronic renal anemia |
| Primary sponsor | F. Hoffmann-La Roche Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Czech Republic;Hungary;Finland;Spain;Austria;Denmark;Germany;Norway;United Kingdom;Italy;Sweden |
| Conditions | Patient with chronic renal anaemia |
| Interventions | Product Name: N/A Product Code: RO0503821 Pharmaceutical Form: Solution for injection INN or Proposed INN: not available yet Other descriptive name: Methoxy polyethylene glycol-epoetin beta Concentration unit: µg/ml microgram(s)/millilitre… |
| Registration date | Dec 11, 2004 |
| Target size | 1000 |
| Secondary IDs | BH 18387 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: